Walleye Capital
BMY icon

Walleye Capital’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7M Buy
112,217
+94,133
+521% +$5.95M 0.01% 1575
2026
Q2 		$1.04M Buy
18,084
+18,006
+23,085% +$1.03M ﹤0.01% 2081
2026
Q1 		$4.73K Sell
78
-25,141
-100% -$1.47M ﹤0.01% 4200
2025
Q4 		$1.36M Sell
25,219
-168,056
-87% -$8.08M ﹤0.01% 2184
2025
Q3 		$8.72M Buy
193,275
+158,980
+464% +$7.42M 0.03% 606
2025
Q2 		$1.59M Buy
34,295
+27,889
+435% +$1.37M 0.01% 1692
2025
Q1 		$391K Sell
6,406
-95,677
-94% -$5.58M ﹤0.01% 2761
2024
Q4 		$5.77M Buy
102,083
+97,988
+2,393% +$5.47M 0.01% 976
2024
Q3 		$212K Sell
4,095
-178,207
-98% -$8.36M ﹤0.01% 3971
2024
Q2 		$7.57M Buy
+182,302
New +$8.16M 0.01% 958
2023
Q4 		– Sell
-223,808
Closed -$11.7M – 4952
2023
Q3 		$13M Buy
+223,808
New +$13.7M 0.03% 434
2022
Q2 		– Sell
-18,007
Closed -$1.32M – 2377
2022
Q1 		$1.32M Sell
18,007
-36,897
-67% -$2.48M 0.04% 507
2021
Q4 		$3.42M Buy
+54,904
New +$3.22M 0.11% 204
2020
Q4 		– Sell
-15,809
Closed -$953K – 947
2020
Q3 		$953K Buy
15,809
+8,241
+109% +$496K 0.11% 252
2020
Q2 		$445K Buy
+7,568
New +$453K 0.1% 247
2020
Q1 		– Sell
-4,170
Closed -$268K – 970
2019
Q4 		$268K Buy
4,170
+2,970
+248% +$170K 0.02% 988
2019
Q3 		$61K Buy
1,200
+600
+100% +$28.2K ﹤0.01% 1560
2019
Q2 		$27K Hold
600
– – ﹤0.01% 1486
2019
Q1 		$29K Buy
+600
New +$29.9K ﹤0.01% 1299

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Walleye Capital's BMY Position: Q3 2026 in Review

Walleye Capital increased its Bristol-Myers Squibb (BMY) stake by 521% in Q3 2026, buying an estimated $5.95M and bringing the position to 112,217 shares worth $7M. The position accounts for 0.01% of the portfolio, ranked #1575.

Walleye Capital first reported a position in BMY in Q1 2019 and has held it in 19 quarters since. The position peaked at $13M in Q3 2023. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Walleye Capital held 112,217 shares of Bristol-Myers Squibb worth $7M as of Q3 2026.
  • Walleye Capital bought 94,133 Bristol-Myers Squibb shares in Q3 2026, an estimated $5.95M.
  • Bristol-Myers Squibb made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1575 holding.
  • Walleye Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 19 quarters since.
  • Walleye Capital's Bristol-Myers Squibb position peaked at $13M in Q3 2023.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.